About Micropharma
From basic research to product development Micropharma is focused on innovation. We apply a unique approach to discover novel and commercial probiotic and enzymatic solutions for metabolic diseases. What we do Micropharma Limited discovers and develops bacteria as biotherapeutics for metabolic diseases. The Company uses its proprietary discovery and development platform ProSelect to screen and select bacteria capable of expressing phenotypic traits that can effectively target metabolic pathways recognized as having therapeutic potential. Micropharma then uses its novel fermentation and optimization techniques to induce over-expression of these traits.
|
|
|
11-50 employees
View all Micropharma employees
|
|
Biotechnology Research
|
|
514-524-2828
|
|
Montréal, Quebec
|
|
2004
|
Micropharma Alternatives
Frequently Asked Questions about Micropharma
Fasil Tarekegn is the CEO of Micropharma.
The decision makers in Micropharma are Fasil Tarekegn, Mohd Ikram, Robert Semmens, etc. Click to Find Micropharma decision makers emails.
Micropharma Staff Directory
Search Micropharma Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
